Thevenot Paul T, Sierra Rosa A, Raber Patrick L, Al-Khami Amir A, Trillo-Tinoco Jimena, Zarreii Parisa, Ochoa Augusto C, Cui Yan, Del Valle Luis, Rodriguez Paulo C
Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA; Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Immunity. 2014 Sep 18;41(3):389-401. doi: 10.1016/j.immuni.2014.08.015.
Adaptation of malignant cells to the hostile milieu present in tumors is an important determinant of their survival and growth. However, the interaction between tumor-linked stress and antitumor immunity remains poorly characterized. Here, we show the critical role of the cellular stress sensor C/EBP-homologous protein (Chop) in the accumulation and immune inhibitory activity of tumor-infiltrating myeloid-derived suppressor cells (MDSCs). MDSCs lacking Chop had decreased immune-regulatory functions and showed the ability to prime T cell function and induce antitumor responses. Chop expression in MDSCs was induced by tumor-linked reactive oxygen and nitrogen species and regulated by the activating-transcription factor-4. Chop-deficient MDSCs displayed reduced signaling through CCAAT/enhancer-binding protein-β, leading to a decreased production of interleukin-6 (IL-6) and low expression of phospho-STAT3. IL-6 overexpression restored immune-suppressive activity of Chop-deficient MDSCs. These findings suggest the role of Chop in tumor-induced tolerance and the therapeutic potential of targeting Chop in MDSCs for cancer immunotherapy.
恶性细胞对肿瘤中存在的恶劣环境的适应是其生存和生长的重要决定因素。然而,肿瘤相关应激与抗肿瘤免疫之间的相互作用仍未得到充分表征。在这里,我们展示了细胞应激传感器C/EBP同源蛋白(Chop)在肿瘤浸润性髓系来源抑制细胞(MDSC)的积累和免疫抑制活性中的关键作用。缺乏Chop的MDSC免疫调节功能降低,并显示出启动T细胞功能和诱导抗肿瘤反应的能力。MDSC中的Chop表达由肿瘤相关的活性氧和氮物种诱导,并由激活转录因子4调节。Chop缺陷的MDSC通过CCAAT/增强子结合蛋白-β的信号传导减少,导致白细胞介素-6(IL-6)产生减少和磷酸化STAT3表达降低。IL-6过表达恢复了Chop缺陷的MDSC的免疫抑制活性。这些发现表明Chop在肿瘤诱导的耐受性中的作用以及靶向MDSC中的Chop进行癌症免疫治疗的潜力。